Clinical Trial

Trial Protocol ID USOR 20298_VS-6766-201 GOG 3052 *STAR*

Trial Description

A Phase 2 Study of VS-6766 (Dual RAF/MEK Inhibitor) Alone and In Combination with Defactinib (FAK Inhibitor) in Recurrent Low-Grade Serous Ovarian Cancer (LGSOC)

View on ClinicalTrials.gov

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Investigator

  • Carol Tweed, M.D.

Disease Types

Sponsor

  • GOG Foundation Verastem Inc.

ClinicalTrials.gov NCT ID

  • NCT04625270